4.7 Article

CSF biomarkers in Olmsted County Evidence of 2 subclasses and associations with demographics

Journal

NEUROLOGY
Volume 95, Issue 3, Pages E256-E267

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000009874

Keywords

-

Funding

  1. NIA [U01 AG006786, P50 AG016574]
  2. GHR Foundation
  3. Mayo Foundation for Medical Education and Research

Ask authors/readers for more resources

Objective We studied interrelationships between CSF biomarkers and associations withAPOE epsilon 4 genotype, demographic variables, vascular variables, and clinical diagnosis in Olmsted County, Minnesota. Methods We included 774 Mayo Clinic Study of Aging participants (693 cognitively unimpaired [CU]; 71 with mild cognitive impairment [MCI]). CSF beta-amyloid 42 (A beta 42), total tau (t-tau), and hyperphosphorylated tau (p-tau) were analyzed using A beta 42 CSF, t-tau CSF, and p-tau (181P) CSF electrochemiluminescence immunoassays. Bivariate mixture models were used to evaluate latent classes. We used linear regression models to evaluate independent associations ofAPOE epsilon 4, demographic factors, cardiovascular risk, and diagnosis with CSF biomarker levels. Results were weighted back to the Olmsted County population. Results Interrelationships between CSF A beta 42 and p-tau/t-tau were consistent with 2 latent classes in the general population. In subgroup 1 (n = 547 [71%]), we found a strong positive correlation between A beta 42 and p-tau (rho = 0.81), while the correlation was much smaller in group 2 (rho = 0.26, n = 227 [29%]). Group 2 was associated with older age,APOE epsilon 4 genotype, a diagnosis of MCI, and elevated amyloid PET. Overall,APOE epsilon 4 genotype and MCI were associated with A beta 42, while age was associated with p-tau/t-tau. There were no associations with sex, education, or vascular risk. Conclusion We hypothesize the population without dementia can be subdivided into participants with and without biological Alzheimer disease (AD) based on the combination of CSF A beta 42 and p-tau/t-tau (represented also by the p-tau/t-tau/A beta 42 ratio). In those without biological AD, common factors such as CSF dynamics may cause a positive correlation between CSF A beta 42 and p-tau/t-tau, while AD leads to dissociation of these proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging

Janina Krell-Roesch, Martin Rakusa, Jeremy A. Syrjanen, Argonde C. van Harten, Val J. Lowe, Clifford R. Jack, Walter K. Kremers, David S. Knopman, Gorazd B. Stokin, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda

Summary: This study examined the association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms in older non-demented adults. The results showed that lower CSF Aβ42 and higher t-tau/Aβ42 and p-tau/Aβ42 ratios were associated with depression, anxiety, and other NPS.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Biomarker clustering in autosomal dominant Alzheimer's disease

Patrick H. Luckett, Charlie Chen, Brian A. Gordon, Julie Wisch, Sarah B. Berman, Jasmeer P. Chhatwal, Carlos Cruchaga, Anne M. Fagan, Martin R. Farlow, Nick C. Fox, Mathias Jucker, Johannes Levin, Colin L. Masters, Hiroshi Mori, James M. Noble, Stephen Salloway, Peter R. Schofield, Adam M. Brickman, William S. Brooks, David M. Cash, Michael J. Fulham, Bernardino Ghetti, Clifford R. Jack, Jonathan Voeglein, William E. Klunk, Robert Koeppe, Yi Su, Michael Weiner, Qing Wang, Daniel Marcus, Deborah Koudelis, Nelly Joseph-Mathurin, Lisa Cash, Russ Hornbeck, Chengjie Xiong, Richard J. Perrin, Celeste M. Karch, Jason Hassenstab, Eric McDade, John C. Morris, Tammie L. S. Benzinger, Randall J. Bateman, Beau M. Ances

Summary: This study analyzed 19 biomarkers of Alzheimer's disease using hierarchical clustering and feature selection, and found that amyloid and tau measures were the primary predictors. Emerging biomarkers of neuronal integrity and inflammation showed weaker predictive ability.

ALZHEIMERS & DEMENTIA (2023)

Article Geriatrics & Gerontology

Association of Indication for Hospitalization with Subsequent Amyloid PET and MRI Biomarkers

Juraj Sprung, Mariana L. Laporta, David S. Knopman, Ronald C. Petersen, Michelle M. Mielke, Clifford R. Jack, David P. Martin, Andrew C. Hanson, Darrell R. Schroeder, Phillip J. Schulte, Scott A. Przybelski, Diana J. Valencia Morales, Toby N. Weingarten, Prashanthi Vemuri, David O. Warner

Summary: This study found that hospitalization in older adults is associated with accelerated cortical thinning, amyloid accumulation, and white matter hyperintensities (WMH) increases, especially in medical hospitalizations. However, these changes were modest and did not translate to an increased risk of crossing the abnormality threshold.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Physical Frailty and Brain White Matter Abnormalities: The Atherosclerosis Risk in Communities Study

Emma L. Ducca, Gabriela T. Gomez, Priya Palta, Kevin J. Sullivan, Clifford R. Jack, David S. Knopman, Rebecca F. Gottesman, Jeremy Walston, B. Gwen Windham, Keenan A. Walker

Summary: The study found a strong association between cerebral white matter structure and current and future frailty. Specifically, white matter hyperintensity volume was significantly associated with frailty. However, measures of white matter microstructure were not generally associated with progression from nonfrail to frail status.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Relationships of Cerebral Perfusion With Gait Speed Across Systolic Blood Pressure Levels and Age: A Cohort Study

B. Gwen Windham, Michael E. Griswold, Radhikesh Ranadive, Kevin Sullivan, Thomas H. Mosley, Michelle M. Mielke, Clifford R. Jack, Dave Knopman, Ron Petersen, Prashanthi Vemuri

Summary: This study aimed to examine if the association between cerebral perfusion and gait speed is influenced by systolic blood pressure and age. The results showed that poorer cerebral perfusion is associated with slower gait speeds, particularly with older age, while higher perfusion can significantly attenuate age-related differences in gait speed.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Clinical Neurology

APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

Neha Atulkumar Singh, Nirubol Tosakulwong, Jonathan Graff-Radford, Mary M. Machulda, Nha Trang Thu Pham, Irene Sintini, Stephen D. Weigand, Christopher G. Schwarz, Matthew L. Senjem, Minerva M. Carrasquillo, Nilufer Ertekin-Taner, Clifford R. Jack, Val J. Lowe, Keith A. Josephs, Jennifer L. Whitwell

Summary: APOE epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), but its influence in atypical presentations of AD is not well-known. This study found that APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau deposition, while non-carriers showed faster rates of atrophy and tau accumulation in certain brain regions.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Association of neighborhood socioeconomic disadvantage and cognitive impairment

Maria Vassilaki, Jeremiah A. Aakre, Anna Castillo, Alanna M. Chamberlain, Patrick M. Wilson, Walter K. Kremers, Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, Rabe E. Alhurani, Jonathan Graff-Radford, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack, David S. Knopman, Ronald C. Petersen

Summary: The study found an association between neighborhood socioeconomic deprivation and cognitive decline, mild cognitive impairment, and dementia in older adults. Higher levels of neighborhood deprivation were associated with an increased risk of progression to dementia and slightly faster cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers

Michael W. Weiner, Danielle Harvey, Susan M. Landau, Dallas P. Veitch, Thomas C. Neylan, Jordan H. Grafman, Paul S. Aisen, Ronald C. Petersen, Clifford R. Jack, Duygu Tosun, Leslie M. Shaw, John Q. Trojanowski, Andrew J. Saykin, Jacqueline Hayes, Charles De Carli

Summary: The study found no significant association between TBI and/or PTSD and biomarker-defined AD. Veterans with TBI and/or PTSD had poorer cognitive status, which may be attributed to other comorbid pathologies.

ALZHEIMERS & DEMENTIA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus

Emanuele Camerucci, Jonathan Graff-Radford, David T. Jones, Benjamin D. Elder, Jeffrey L. Gunter, Jeremy K. Cutsforth-Gregory, Hugo Botha, Matthew C. Murphy, Derek R. Johnson, Caroline Davidge-Pitts, Clifford R. Jack, John Huston, Petrice M. Cogswell

Summary: This study evaluated the change in size of focally enlarged sulci (FES) and pituitary height after shunt placement in patients with idiopathic normal pressure hydrocephalus (iNPH). The results showed a significant decrease in FES volume and a significant increase in pituitary gland size after shunt placement.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Clinical Neurology

Predicting amyloid PET and tau PET stages with plasma biomarkers

Clifford R. Jack Jr, Heather J. Wiste, Alicia Algeciras-Schimnich, Dan J. Figdore, Christopher G. Schwarz, Val J. Lowe, Vijay K. Ramanan, Prashanthi Vemuri, Michelle M. Mielke, David S. Knopman, Jonathan Graff-Radford, Bradley F. Boeve, Kejal Kantarci, Petrice M. Cogswell, Matthew L. Senjem, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen

Summary: Staging the severity of Alzheimer's disease pathology is important for therapeutic trials and clinical prognosis. Biomarkers such as amyloid and tau PET can be used for disease staging, but plasma biomarkers would be more practical.

BRAIN (2023)

Article Clinical Neurology

Changes in Cardiovascular Health Across Midlife and Late-Life and Magnetic Resonance Imaging Markers of Cerebral Vascular Disease in Late-Life

Sanaz Sedaghat, Yuekai Ji, Jean-Philippe Empana, Timothy M. Hughes, Thomas H. Mosley, Rebecca F. Gottesman, Michael Griswold, Clifford R. Jack, Pamela L. Lutsey, Thomas T. van Sloten

Summary: This study aimed to investigate the association of cardiovascular health in midlife and late-life as well as changes in cardiovascular health between these periods with the prevalence of cerebral vascular disease in late-life. The results showed that better cardiovascular health in midlife, improvement of cardiovascular health within midlife, higher cardiovascular health at late-life, and improvement of cardiovascular health from midlife to late-life were associated with a lower prevalence of cerebral vascular disease markers in late-life. Therefore, improving cardiovascular health in midlife and late-life may help prevent the development of cerebral vascular disease.

STROKE (2023)

Article Clinical Neurology

Altered within- and between-network functional connectivity in atypical Alzheimer's disease

Neha Atulkumar Singh, Peter R. Martin, Jonathan Graff-Radford, Irene Sintini, Mary M. Machulda, Joseph R. Duffy, Jeffrey L. Gunter, Hugo Botha, David T. Jones, Val J. Lowe, Clifford R. JackJr, Keith A. Josephs, Jennifer L. Whitwell

Summary: Posterior cortical atrophy and logopenic progressive aphasia are atypical clinical presentations of Alzheimer's disease, both showing disruptions in functional networks. The language network is affected in logopenic progressive aphasia, while the visual network is affected in posterior cortical atrophy. However, there is limited knowledge about the differences in connectivity within and between brain networks in these atypical Alzheimer's disease phenotypes.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease

Nick Corriveau-Lecavalier, Jeffrey L. Gunter, Michael Kamykowski, Ellen Dicks, Hugo Botha, Walter K. Kremers, Jonathan Graff-Radford, Daniela A. Wiepert, Christopher G. Schwarz, Essa Yacoub, David S. Knopman, Bradley F. Boeve, Kamil Ugurbil, Ronald C. Petersen, Clifford R. Jack, Melissa J. Terpstra, David T. Jones

Summary: From a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Age-related disruption of the default mode network is accelerated by amyloid deposition in all syndromic presentations of Alzheimer's disease, while syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. This study investigates the use of a biomarker of default mode network dysfunction, the network failure quotient, to assess Alzheimer's disease in a normative cohort and differentiate between different phenotypes of the disease. The study provides important insights into the shared pathophysiological mechanisms and distinct neurodegenerative processes involved in Alzheimer's disease.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume The ARIC Study

Keenan A. Walker, Ron C. Hoogeveen, Aaron R. Folsom, Christie M. Ballantyne, David S. Knopman, B. Gwen Windham, Clifford R. Jack Jr, Rebecca F. Gottesman

Summary: In the article "Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume: The ARIC Study" by Walker et al., coding errors were found to have affected the statistical analyses. The authors have corrected the errors and reanalyzed the data, stating that the errors did not change the overall message of the article. The identified errors include misclassification of a nominal covariate, use of incorrect alcohol use covariate, and an error in the scaling of beta coefficients.

NEUROLOGY (2023)

Article Clinical Neurology

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Rioghna R. Pittock, Jeremiah A. Aakre, Anna M. Castillo, Vijay K. Ramanan, Walter K. Kremers, Clifford R. Jack Jr, Prashanthi Vemuri, Val J. Lowe, David S. Knopman, Ronald C. Petersen, Jonathan Graff-Radford, Maria Vassilaki

Summary: Treatment options for Alzheimer's disease are limited, and research on the applicability of anti-beta-amyloid monoclonal antibodies in the general population is lacking. This study aims to assess the generalizability of anti-amyloid treatment and apply the eligibility criteria of two clinical trials to a population-based sample.

NEUROLOGY (2023)

No Data Available